The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) announced Project Call 8.1 for Technology, Workforce Development, and Global Health Fund projects. NIIMBL intends to make up to $4M available for technology and workforce development and up to $1.7M for Global Health Fund projects. The concept submission deadline is September 30, 2024. Submitters must be a NIIMBL member.
The Technology Request for Proposals (RFP) focuses on Process Analytical Technology (PAT) and Manufacturing Platforms for Biopharmaceutical Products. Specific technical topic areas include:
Process Analytical Technology and Control for Biopharmaceutical Manufacturing
- In-line Monitoring and Multivariate Analysis (MVA)
- Real-time Analytical Technologies
- Advanced Sensors
Manufacturing Platforms for Biopharmaceutical Products
- Robust Analytical Tools
- Expression Systems for Viral Vectors
- Solid-phase Growth Factor Delivery Vehicles
- Automated RNA and DNA Extraction Devices
- Custom Bioreactors
- Efficient Cell Washing and Concentration Technologies
Workforce topic areas aim to broaden awareness of biopharmaceutical manufacturing careers. Topics include:
- Increasing Knowledge and Interest in Biopharma Manufacturing Careers
- Increasing Participation and Enrollment in Education and Training Programs
- Internship and Immersion Experiences
- Innovative Talent Pipeline Partnerships
The Global Health Fund was established by NIIMBL with funding from the Bill & Melinda Gates Foundation. This Global Health Fund RFP focuses on mRNA/LNP alternatives and lowering the cost of goods for mRNA vaccine manufacturing.
"Our Project Calls serve as a catalyst for accelerating the development, commercialization, and adoption of new innovations in manufacturing technologies and workforce initiatives. By investing in member-led project teams through these calls, we aim to foster a collaborative environment that drives industry competitiveness and encourages the adoption of advanced practices. We are excited about the potential high-impact projects that will emerge from this latest call, furthering our mission through strategic partnerships and investments," said Sandeep Kedia, Sr. Technology Fellow and Project Call Program Leader.
Visit the Project Call 8.1 webpage for full RFPs, key dates, and important information.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!